MontelukastLevocetirizineQualityChecker

Montelukast Levocetirizine

API assay biosimilars dissolution fixed-dose combinations generics impurities market map
Open selection

Montelukast Levocetirizine Quality Checker — Combo Product (Asthma/Allergy)

ℹ️ The utility checks content of both APIs, montelukast sulfoxide, dextrocetirizine, moisture, uniformity.
ℹ️ Does not use machine learning — rule-based logic only.
⚠️ CRITICAL! Montelukast Sulfoxide ≤0.5%. Dextrocetirizine ≤0.1%. Moisture ≤0.5%!

Usage:
MontelukastLevocetirizineQualityChecker.exe → demo mode
MontelukastLevocetirizineQualityChecker.exe input.csv output.json → evaluate data

Input format:
BatchNumber,Montelukast_Content_Percent,Levocetirizine_Content_Percent,Montelukast_Sulfoxide_Percent,Montelukast_E_Z_Isomer_Percent,Montelukast_Total_Impurities_Percent,Dextrocetirizine_Percent,Levocetirizine_Total_Impurities_Percent,Total_All_Impurities_Percent,Loss_On_Drying_Percent,Heavy_Metals_ppm,Dissolution_Montelukast_30min_Percent,Dissolution_Levocetirizine_30min_Percent,Content_Uniformity_RSD,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected

Example:
MON-LEV-2026-001,98.8,99.2,0.2,0.15,0.5,0.05,0.2,0.8,0.3,6,88.0,94.0,4.2,30,8,0,0

— WHY IS THIS NEEDED?
Montelukast + Levocetirizine combination used for allergic rhinitis and asthma:
• Montelukast is highly unstable to light and moisture, easily oxidizing to sulfoxide (inactive/toxic). Moisture and sulfoxide control is critical.
• Levocetirizine must be enantiomerically pure. Presence of dextrocetirizine (inactive isomer) is unacceptable.
• Montelukast dose is small (usually 10 mg), so Content Uniformity (CU) is strictly controlled.
• Synchronous release of both components necessary for comprehensive therapeutic effect.
⚠️ CRITICAL:
• Content of both APIs: 95–105%
• Montelukast Sulfoxide: ≤ 0.5% (degradation product)
• Dextrocetirizine: ≤ 0.1% (chiral impurity)
• Moisture (LOD): ≤ 0.5% (critical for montelukast stability)
• Uniformity (RSD): ≤ 6.0%
• Dissolution: ≥ 80% in 30 min for both components
• Microbiology: absence of pathogens
⚠️ Note: Utility focuses on montelukast stability and levocetirizine chiral purity. Exceeding sulfoxide level indicates violation of manufacturing or storage conditions (light/moisture). High moisture leads to rapid montelukast degradation in tablet. Dextrocetirizine control important as it lacks antihistamine activity and increases body load.

input.csv

BatchNumber,Montelukast_Content_Percent,Levocetirizine_Content_Percent,Montelukast_Sulfoxide_Percent,Montelukast_E_Z_Isomer_Percent,Montelukast_Total_Impurities_Percent,Dextrocetirizine_Percent,Levocetirizine_Total_Impurities_Percent,Total_All_Impurities_Percent,Loss_On_Drying_Percent,Heavy_Metals_ppm,Dissolution_Montelukast_30min_Percent,Dissolution_Levocetirizine_30min_Percent,Content_Uniformity_RSD,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected
MON-LEV-2026-001,98.8,99.2,0.2,0.15,0.5,0.05,0.2,0.8,0.3,6,88.0,94.0,4.2,30,8,0,0

URS & FS — user requirements and functional specification

This document defines user requirements and functional specification for the quality-control utility. It supports deployment discussion, IQ/OQ preparation and QC workflow integration.

Utility: MontelukastLevocetirizineQualityCheckerAPI / object: Montelukast LevocetirizineCategory: Global API

1. Scope

The Montelukast Levocetirizine Quality Checker utility is used for Montelukast Levocetirizine. The actual input.csv is the source of truth for the input structure; control criteria are defined by the executable and the domain description.

The utility does not use machine learning; decisions are produced by deterministic rules.

Categories: Global API

Tags: API, assay, biosimilars, dissolution, fixed-dose combinations, generics, impurities, market map, microbiology, solid dosage, uniformity

2. Execution modes

MontelukastLevocetirizineQualityChecker.exe                            → demo mode
MontelukastLevocetirizineQualityChecker.exe input.csv output.json      → evaluate data

3. Key controlled areas

  • assay / content
  • dissolution / disintegration
  • microbiology and pathogens
  • heavy metals / elemental impurities

4. Domain limits and critical parameters

  • ⚠️ CRITICAL! Montelukast Sulfoxide ≤0.5%. Dextrocetirizine ≤0.1%. Moisture ≤0.5%!
  • ⚠️ CRITICAL:
  • Content of both APIs: 95–105%
  • Montelukast Sulfoxide: ≤ 0.5% (degradation product)
  • Dextrocetirizine: ≤ 0.1% (chiral impurity)
  • Moisture (LOD): ≤ 0.5% (critical for montelukast stability)
  • Uniformity (RSD): ≤ 6.0%
  • Dissolution: ≥ 80% in 30 min for both components
  • Microbiology: absence of pathogens
  • ⚠️ Note: Utility focuses on montelukast stability and levocetirizine chiral purity. Exceeding sulfoxide level indicates violation of manufacturing or storage conditions (light/moisture). High moisture leads to rapid montelukast degradation in tablet. Dextrocetirizine control important as it lacks antihistamine activity and increases body load.
Limits stated in the description must be verified against the current approved specification, pharmacopoeial monograph and registration dossier before production use.

5. URS — user requirements

IDRequirementCriticalityAcceptance criterion
URS-001The system shall accept an input.csv file for Montelukast Levocetirizine with the exact columns listed in the “Input data contract” section.HighA file with the correct header is processed without manual editing; missing mandatory columns produce FAIL/import error.
URS-002The system shall support execution without arguments in demo mode and execution with input.csv output.json for user data.MediumBoth execution scenarios produce a predictable result or clear diagnostic error.
URS-003The system shall perform rule-based controls for: assay / content, dissolution / disintegration, microbiology and pathogens, heavy metals / elemental impurities.HighEach controlled parameter receives a status and message; the result does not depend on hidden Excel formulas or ML.
URS-004The system shall preserve traceability between batch/lot, source values, applied rules and final verdict.HighOutput includes batch identifier, source values, parameter statuses and critical findings.
URS-005The system shall generate machine-readable output.json for LIMS/ELN/MES, batch record and QA/QC review.HighJSON contains overall status, check array, warnings, failures and source-file reference.
URS-006The system shall support use in the client validation package: URS/FS, IQ/OQ preparation, installation and operational scenario checks.HighThe document, test scenarios and reproducible CSV/JSON flow are suitable for audit and internal approval.
URS-007The system shall clearly separate technical data errors from specification nonconformities.MediumSchema/type errors are not mixed with pharmacopoeial deviations and are reported separately.

6. input.csv data contract

The source of truth for the input schema is the actual input.csv header. Column names are technical identifiers and are not translated.

#ColumnTypeUnitDescriptionSampleControl rule
1BatchNumberidentifieras specifiedBatch NumberMON-LEV-2026-001mandatory field; used for batch/lot traceability
2Montelukast_Content_Percentdecimal%Montelukast Content %98.8numeric value; compared with assay/purity limit from specification or method
3Levocetirizine_Content_Percentdecimal%Levocetirizine Content %99.2numeric value; compared with assay/purity limit from specification or method
4Montelukast_Sulfoxide_Percentdecimal%Montelukast Sulfoxide %0.2mandatory numeric value; rule comparison is performed by the utility
5Montelukast_E_Z_Isomer_Percentdecimal%Montelukast E Z Isomer %0.15mandatory numeric value; rule comparison is performed by the utility
6Montelukast_Total_Impurities_Percentdecimal%Montelukast Total Impurities %0.5mandatory numeric value; rule comparison is performed by the utility
7Dextrocetirizine_Percentdecimal%Dextrocetirizine %0.05mandatory numeric value; rule comparison is performed by the utility
8Levocetirizine_Total_Impurities_Percentdecimal%Levocetirizine Total Impurities %0.2mandatory numeric value; rule comparison is performed by the utility
9Total_All_Impurities_Percentdecimal%Total All Impurities %0.8mandatory numeric value; rule comparison is performed by the utility
10Loss_On_Drying_Percentdecimal%Loss On Drying %0.3mandatory numeric value; rule comparison is performed by the utility
11Heavy_Metals_ppmdecimalppmHeavy Metals ppm6numeric value; checked as elemental/metal impurity
12Dissolution_Montelukast_30min_Percentdecimal%Dissolution Montelukast 30min %88.0numeric value; dissolution/disintegration profile checked according to method
13Dissolution_Levocetirizine_30min_Percentdecimal%Dissolution Levocetirizine 30min %94.0numeric value; dissolution/disintegration profile checked according to method
14Content_Uniformity_RSDdecimalas specifiedContent Uniformity RSD4.2numeric value; compared with assay/purity limit from specification or method
15Microbial_Count_TAMCdecimalas specifiedMicrobial Count TAMC30numeric value; compared with microbiological limits
16Microbial_Count_TYMCdecimalas specifiedMicrobial Count TYMC8numeric value; compared with microbiological limits
17EColi_Detectedboolean / flag0/1EColi Detected0valid flag required; prohibited organisms and growth are normally expected as 0 / absent
18Salmonella_Detectedboolean / flag0/1Salmonella Detected0valid flag required; prohibited organisms and growth are normally expected as 0 / absent

CSV example

BatchNumber,Montelukast_Content_Percent,Levocetirizine_Content_Percent,Montelukast_Sulfoxide_Percent,Montelukast_E_Z_Isomer_Percent,Montelukast_Total_Impurities_Percent,Dextrocetirizine_Percent,Levocetirizine_Total_Impurities_Percent,Total_All_Impurities_Percent,Loss_On_Drying_Percent,Heavy_Metals_ppm,Dissolution_Montelukast_30min_Percent,Dissolution_Levocetirizine_30min_Percent,Content_Uniformity_RSD,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected
MON-LEV-2026-001,98.8,99.2,0.2,0.15,0.5,0.05,0.2,0.8,0.3,6,88.0,94.0,4.2,30,8,0,0

7. FS — functional specification

IDFunctionImplementation description
FS-001CLI entry pointThe executable MontelukastLevocetirizineQualityChecker.exe supports demo mode and input.csv output.json processing mode.
FS-002CSV parserThe import module reads CSV, validates header, column presence/order, value count and encoding. Decimal values are expected with a dot separator.
FS-003Field conversionEach column is converted to the expected type: identifier, text, decimal number, date/time or boolean flag.
FS-004Domain rule engineFor Montelukast Levocetirizine, explicit rules are applied: range, minimum, maximum, absence of prohibited flag, data completeness or calculation-based check.
FS-005Criticality handlingCritical violations produce FAIL; non-critical deviations and incomplete data produce WARNING; full conformance produces PASS.
FS-006JSON writeroutput.json stores overall status, per-parameter results, source values, warnings, failures and diagnostic messages.
FS-007Integration contractThe CSV → JSON format is stable for invocation from LIMS/ELN/MES, scheduled task or wrapper service.
FS-008Error handlingSchema error, missing file, non-numeric value or JSON write failure returns diagnosable error without silent PASS.

8. output.json contract

The output file must be suitable for automated processing, audit review and correlation with the source input.csv row.

{
  "utility": "MontelukastLevocetirizineQualityChecker",
  "api": "Montelukast Levocetirizine",
  "batchNumber": "MON-LEV-2026-001",
  "overallStatus": "PASS|WARNING|FAIL",
  "checkedAtUtc": "2026-05-18T00:00:00Z",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "MON-LEV-2026-001",
      "unit": "as specified",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Montelukast_Content_Percent",
      "value": "98.8",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Levocetirizine_Content_Percent",
      "value": "99.2",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Montelukast_Sulfoxide_Percent",
      "value": "0.2",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Montelukast_E_Z_Isomer_Percent",
      "value": "0.15",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Montelukast_Total_Impurities_Percent",
      "value": "0.5",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Dextrocetirizine_Percent",
      "value": "0.05",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Levocetirizine_Total_Impurities_Percent",
      "value": "0.2",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": [],
  "sourceFile": "input.csv"
}

9. OQ/PQ test scenarios

IDScenarioExpected result
TC-001Valid CSV with expected header and sample rowAll rows are processed; output contains PASS/WARNING/FAIL and parameter-level detail.
TC-002A mandatory input.csv column is missingImport is rejected or the row receives FAIL with schema reference.
TC-003A numeric field contains text or a blank valueType conversion error is recorded; the result is not hidden as PASS.
TC-004A parameter is outside specification or critical limitCritical parameters produce FAIL; non-critical deviations produce WARNING according to the rule.
TC-005Positive pathogen/microbiological flag or microbiological limit excursionCritical FAIL is produced with the offending parameter.
TC-006Insufficient dissolution or excessive disintegration timeFAIL/WARNING is produced according to method criticality.

10. QA/QC, CSV and change control

  • Before production use, the client records executable version, checksum, specification/monograph version, test CSV, expected JSON and IQ/OQ results.
  • Column names must not be changed without updating the validator and test scenarios.
  • The source CSV, output.json and utility version should be stored together as an evidence package.
  • Any change in control rules must go through change control and repeated OQ scenario verification.

Included in packages

ENT QC Suite

QC package for ENT: nasal sprays, ear drops, local antiseptics, corticosteroids, antibiotics and upper-airway medicines.

Open

Global API & Biosimilars QC Suite

Package for high-demand global APIs, generics and biosimilars, including fixed-dose combinations and biological products.

Open